Get the Stockscreener App
7.96
4.56%
-0.38
After Hours:
8.00
0.04
+0.50%
Neogenomics Inc stock is traded at $7.96, with a volume of 1.86M.
It is down -4.56% in the last 24 hours and up +30.92% over the past month.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
See More
Previous Close:
$8.34
Open:
$8.38
24h Volume:
1.86M
Relative Volume:
0.75
Market Cap:
$1.03B
Revenue:
$628.25M
Net Income/Loss:
$-78.55M
P/E Ratio:
-12.84
EPS:
-0.62
Net Cash Flow:
$-29.73M
1W Performance:
-0.25%
1M Performance:
+30.92%
6M Performance:
-22.19%
1Y Performance:
-50.86%
1-Day Range:
$7.905
$8.38
1-Week Range:
$7.36
$8.42
52-Week Range:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Name
Neogenomics Inc
Sector
Industry
Phone
(239) 768-0600
Address
9490 NEOGENOMICS WAY, FORT MYERS, FL
Compare NEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
7.96 | 966.26M | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-29-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-15-25 | Initiated | Guggenheim | Neutral |
| Apr-30-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-13-25 | Downgrade | The Benchmark Company | Buy → Hold |
| Dec-10-24 | Initiated | Jefferies | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Aug-21-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-09-23 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Feb-01-23 | Upgrade | Needham | Hold → Buy |
| Aug-26-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-22-22 | Downgrade | Needham | Buy → Hold |
| Jun-03-22 | Initiated | Piper Sandler | Overweight |
| Mar-29-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-29-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-18-22 | Resumed | Stephens | Overweight |
| Dec-16-21 | Initiated | Cowen | Outperform |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-25-21 | Resumed | Needham | Buy |
| Feb-25-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-28-21 | Initiated | Truist | Buy |
| Dec-11-20 | Resumed | BTIG Research | Buy |
| Oct-28-20 | Reiterated | Needham | Buy |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Aug-28-20 | Initiated | Guggenheim | Buy |
| Jul-29-20 | Reiterated | Needham | Buy |
| Jun-25-20 | Initiated | BofA/Merrill | Buy |
| Apr-21-20 | Resumed | Stephens | Overweight |
| Mar-02-20 | Resumed | Craig Hallum | Buy |
| Feb-28-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jan-23-20 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-01-19 | Reiterated | Needham | Buy |
| Mar-29-19 | Reiterated | Needham | Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Oct-24-18 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Aug-21-18 | Initiated | Leerink Partners | Outperform |
| May-02-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Sep-11-17 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-24-17 | Initiated | Gabelli & Co | Buy |
| Dec-15-16 | Initiated | Cantor Fitzgerald | Overweight |
View All
Neogenomics Inc Stock (NEO) Latest News
Intraday pattern recognizer results for NeoGenomics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Technical signs of recovery in NeoGenomics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Applying sector rotation models to NeoGenomics Inc.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
Has NeoGenomics Inc. found a price floorWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Fred Alger Management LLC Sells 138,182 Shares of NeoGenomics, Inc. $NEO - MarketBeat
Why NeoGenomics (NEO) Shares Are Falling Today - Yahoo Finance
Why Natera (NTRA) Shares Are Falling Today - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - FinancialContent
What are NeoGenomics Inc.’s recent SEC filings showing2025 Volume Leaders & Safe Capital Growth Tips - Lancaster City Council
Northern Trust Corp Cuts Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Price Floor Holding on NeoGenomics Inc. — Rebound PossibleJuly 2025 PostEarnings & Low Volatility Stock Recommendations - beatles.ru
What are the future prospects of NeoGenomics Inc.Swing Trade & Scalable Portfolio Growth Methods - beatles.ru
NeoGenomics (NASDAQ:NEO) Shares Down 5.2%Should You Sell? - MarketBeat
Should value investors consider NeoGenomics Inc.2025 Key Lessons & Fast Moving Stock Trade Plans - beatles.ru
Tech Rally: Why is NeoGenomics Inc. stock going upEarnings Overview Summary & Verified Momentum Stock Watchlist - classian.co.kr
NeoGenomics (NASDAQ:NEO) Given New $11.00 Price Target at Stephens - MarketBeat
First Light Asset Management LLC Has $57.35 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Will NeoGenomics Inc. benefit from geopolitical trendsJuly 2025 Decliners & High Accuracy Investment Entry Signals - خودرو بانک
Hsbc Holdings PLC Lowers Position in NeoGenomics, Inc. $NEO - Defense World
What data driven models say about NeoGenomics Inc.’s future2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Ranking NeoGenomics Inc. among high performing stocks via toolsGold Moves & Breakout Confirmation Trade Signals - Newser
Is now a turning point for NeoGenomics Inc.Market Volume Report & Long Hold Capital Preservation Tips - Newser
Why is NeoGenomics Inc. stock going upPortfolio Gains Summary & Free Accurate Trade Setup Notifications - خودرو بانک
What chart patterns are forming on NeoGenomics Inc.Weekly Profit Summary & Safe Capital Growth Plans - خودرو بانک
Is NeoGenomics Inc. stock a value trapJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - خودرو بانک
NeoGenomics, Inc. $NEO Stock Holdings Lifted by Gabelli Funds LLC - MarketBeat
Published on: 2025-09-04 23:30:35 - Newser
Signal strength of NeoGenomics Inc. stock in tech scannersJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Brown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure - Insider Monkey
What is NeoGenomics Inc. s revenue forecastJuly 2025 Levels & Daily Chart Pattern Signal Reports - خودرو بانک
How to manage a losing position in NeoGenomics Inc.Portfolio Growth Summary & Consistent Return Investment Signals - Newser
Using Python tools to backtest NeoGenomics Inc. strategiesGap Up & Verified Entry Point Signals - Newser
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
How moving averages guide NeoGenomics Inc. tradingJuly 2025 Breakouts & Verified Chart Pattern Signals - Newser
Fed Meeting: How does NeoGenomics Inc. perform in inflationary periodsMarket Performance Recap & Long Hold Capital Preservation Plans - خودرو بانک
NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt - 富途牛牛
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Applying big data sentiment scoring on NeoGenomics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
Real time social sentiment graph for NeoGenomics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Should I trade or invest in NeoGenomics Inc.Market Trend Summary & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
What’s next for NeoGenomics Inc. stock priceGDP Growth & Pattern Based Trade Signal System - Newser
When is the best time to exit NeoGenomics Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Can momentum traders help lift NeoGenomics Inc.Earnings Recap Summary & Fast Entry Momentum Trade Alerts - Newser
Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser
Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - خودرو بانک
Neogenomics Inc Stock (NEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):